S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AKTX Akari Therapeutics PLC

2.28

-0.02 (-0.87%)

Last Updated: 13:13:07

Delayed by 15 minutes

Form 424B3 - Prospectus [Rule 424(b)(3)]

Article too big to display. Click here to view on the SEC website

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics PLC News

Form 8-K - Current report
Friday 8 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Tuesday 15 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 11 October 2024 (1 month ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Wednesday 9 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 4 October 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 2 October 2024 (1 month ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Monday 30 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 18 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 16 September 2024 (2 months ago) • Edgar (US Regulatory)

More Akari Therapeutics PLC News Articles

Eaton Vance High Income ...

Young & Co's Brewery

Brookfield Renewable Par...

Manulife Financial

Catcha Investment

Main Street Capital

Braemar Hotels and Resorts

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions